Little-Known Middlemen Save Money On Medicines — But Maybe Not For You
Kaiser Health News examines the role of PBMs in the prescription drug-pricing pipeline.
Drug Puts A $750,000 ‘Price Tag On Life’
The high cost of Spinraza, a new and promising treatment for spinal muscular atrophy, highlights how the cost-benefit analysis insurers use to make drug coverage decisions plays out in human terms.
States Have Tried Versions Of ‘Skinny Repeal.’ It Didn’t Go Well.
Republican senators are warming to the idea of a scaled-back plan that would delete the Affordable Care Act’s individual and employer mandates but leave the rest of law generally intact. But this approach has caused difficulties in the past.
Cruz Plan Gets Thumbs Up From HHS But Thumbs Down From Most Everyone Else
During another day of fast-moving developments, Senate Republicans signaled their intent to attempt to bring an updated repeal-and-delay bill to the floor for a vote next week.
The failure this week of the U.S. Senate’s ACA repeal effort was one more twist in the ongoing political drama that has complicated routine rate setting for insurers and state officials.
5 Ways The Senate GOP Health Bill Could Change Your Health Plan Options
A key bill provision would likely lower premiums, but coverage would be skimpier with consumers left to figure out the trade-offs.
Should GOP Health Bill Prevail, Say Bye-Bye To Insurance Rebates
A little-noticed provision of the Senate GOP health plan would unwind an Affordable Care Act provision limiting insurer profits, administrative costs.
Winners And Losers: 40 Is Old In Senate GOP Health Plan’s Subsidy Structure
The latest Republican plan to revamp the health law reshapes how age and income affect what help consumers get for paying premiums.
Medical Responses To Opioid Addiction Vary By State, Analysis Finds
The study also found that the largest percentage of medical coverage claims related to opioid abuse and dependence nationally come from older patients — those ages 51 to 60.
Overwrought Marketing? Ads, Not Research, Create Some Pharma Best-Sellers
A look at how and why strategic, star-studded advertising brought a drug for a little-known neurological condition into your home.